An advanced microfluidic technology for isolating circulating tumor cells through continuous centrifugal processing. This technology shifts from conventional positive selection to negative selection methodology, enabling total isolation of rare cells with high precision.
Manufactured by
CTCELLS, Inc.
Seoul, South Korea
CTCELLS is a cutting-edge cancer diagnostics and drug development company, founded on the premise that effective cancer treatment requires tailored solutions for each individual. Leveraging Circulating Tumor Cell (CTC) liquid biopsy technology, CTCELLS leads the industry with its unique automation capabilities, enabling the isolation of all types of circulating tumor cells. With a strong focus on developing innovative cancer treatments, CTCELLS is dedicated to improving patient outcomes by matching cancer characteristics with the most suitable therapies, setting its sights on bringing hope to patients facing challenging cancer types. Join us in our mission to transform the landscape of cancer treatment.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
AcroCyte Therapeutics, Inc.
Taiwan · 2 relevant products
MedFluid Co., Ltd.
Taiwan · 1 relevant product
Metaph Biotech Medical Co.,Ltd.
China · 1 relevant product
53 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →11 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 74 closest product alternatives
AcroCyte Therapeutics, Inc. · Taiwan
A comprehensive 3D cell culturing technology platform that enables rapid expansion of diverse clinical cell samples with reproducible results. The system successfully cultures and expands rare cell populations including CTCs from patient blood specimens. The platform eliminates reliance on traditional cell lines and animal models for research applications.
MedFluid Co., Ltd. · Taiwan
Proprietary microfluidics technology platform designed for point-of-care testing and molecular diagnostics applications. Enables precise fluid handling and sample processing in miniaturized formats for rapid diagnostic analysis.
Metaph Biotech Medical Co.,Ltd. · China
Automated system for isolating and sorting circulating tumor cells (CTCs) from blood samples. Enables non-invasive cancer monitoring, early detection, and treatment response assessment through enumeration and characterization of CTCs. Integrates microfluidic technology with automated image analysis for high-throughput clinical and research applications.
71 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products